15.11.2017 - 16.11.2017Renaissance Woodbridge Hotel, 515 US-1, 08830 Iselin, USA
Time: 8:30 am to 5:30 pm
Kongressthemen The first biosimilar product launched in the US in 2015. Currently there are only 4 biosimilar products approved but the North Americas market continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development.
